Lead Product(s) : Icosapent Ethyl,DHA
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Aker BioMarine
Deal Size : Undisclosed
Deal Type : Collaboration
Aker BioMarine Enters Into Research Collaboration for Alzheimer’s
Details : Université de Sherbrooke in Canada will test if LYSOVETA, Aker BioMarine’s new delivery platform based on LPC-bound EPA/DHA from krill, is more effective in increasing the concentration of DHA in the brain and improving cognition.
Product Name : Lysoveta
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
February 15, 2021
Lead Product(s) : Icosapent Ethyl,DHA
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Aker BioMarine
Deal Size : Undisclosed
Deal Type : Collaboration